Sample preparation partnership
Dionex has partnered with Genevac to reduce solvent use in sample preparation. The result is the release of Genevac?s Rocket evaporator.
Dionex has partnered with Genevac to reduce solvent use in sample preparation. The result is the release of Genevac’s Rocket evaporator, which the companies’ report can perform unattended evaporation and concentration of up to six 450 mL flasks or 18 Dionex ASE tubes in parallel. It is claimed that the patented two-stage cold trap built into the evaporator provides high levels of solvent recovery and fast evaporation, even for the most volatile organic solvents.
Concentration and evaporation is an important step in achieving accurate analytical results with sample extracts. It is also labour intensive. The new evaporator automates this process. It is also reported to help minimize solvent usage, an important consideration for any laboratory seeking to reduce their impact on the environment and save money.
Genevac is a subsidiary of SP Scientific, a manufacturer of specialty equipment for pharmaceutical, biotechnology, industrial, academic and OEM applications. Genevac focuses on evaporation science and engineering.
For details on the evaporator visit www.dionex.com/rocketevaporator
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
